Skip to main content

Pharmacological Treatment of Insomnia

Drugs volume 45, pages 44–55 (1993)Cite this article

Summary

Insomnia is a widespread condition which affects approximately one-third of the general population. It is especially prevalent in the elderly. The treatment modalities of insomnia are varied and include nonpharmacological and pharmacological techniques. Insomnia is a symptom of an underlying condition. Before starting treatment, it is imperative to carefully assess the possible causes of insomnia, since the aetiology of the insomnia determines the treatment.

Pharmacotherapy is indicated in transient insomnia which occurs in otherwise healthy, normal sleepers, and in the treatment of intermittent insomnia in the elderly. Pharmacotherapy is not indicated in chronic insomnia, except perhaps on an intermittent basis and as adjunctive treatment. If adjunctive pharmacotherapy is to be used in chronic insomnia, the possibility of a primary sleep disorder must be ruled out prior to the use of a sedative hypnotic. When using sedative hypnotic agents, the lowest possible dose should be used for the shortest possible time. Special care should be exercised when treating the elderly, because altered pharmacokinetics in this age group may impair tolerability.

Benzodiazepines remain the recommended hypnotic agents, although newer, non-benzodiazepine agents may also be utilised. Despite the relative safety of benzodiazepines, the most common adverse effects include residual daytime sleepiness, rebound insomnia and anterograde amnesia. Short-acting benzodiazepines are more commonly associated with rebound insomnia and withdrawal symptoms, whereas the long acting benzodiazepines are more likely to produce residual daytime sleepiness. Anterograde amnesia may be seen with all benzodiazepines. Use of alcohol for its sedative properties, and over-the-counter preparations, are not recommended for the treatment of insomnia.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

49,54 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  • Allain H, Delahaye CH, Le Coz F, Blin P, Decombe R, et al. Postmarketing surveillance of zopiclone in insomnia: analysis of 20,513 cases. Sleep 14: 408–413, 1991

    PubMed  CAS  Google Scholar 

  • Allen MD, Greenblatt DJ, Arnold JD. Single- and multiple-dose kinetics of estazolam, a triazolol-benzodiazepine. Psychopharmacologia 66: 267–275, 1979

    Article  CAS  Google Scholar 

  • Balkin TJ, O’Donnell VM, Wesensten N, McCan U, Belenky G. Comparison of the daytime sleep and performance effects of zolpidem versus triazolam. Psychopharmacology 107: 83–68, 1992

    PubMed  Article  CAS  Google Scholar 

  • Balter MB, Uhlenhuth EH. The beneficial and adverse effects of hypnotics. Journal of Clinical Psychiatry 52 (Suppl.): 16–23, 1991

    PubMed  Google Scholar 

  • Bootzin RR. A stimulus control treatment for insomnia. In American Psychological Association proceedings, pp. 395–396, American Psychological Association, Washington DC, 1972

    Google Scholar 

  • Boxenbaum HG, Postmanter HN, Macasieb T, et al. Pharmacokinetics of flunitrazepam following single- and multiple-dose administration to healthy human subjects. Journal of Pharmacokinetics and Biopharmaceutics 6: 283–293, 1978

    PubMed  CAS  Google Scholar 

  • Breimer DD, Bracht H, de Boer AG. Plasma level profile of nitrazepam (‘Mogadon’) following oral administration. British Journal of Clinical Pharmacology 4: 709–711, 1977

    Article  CAS  Google Scholar 

  • Breimer DD. Pharmacokinetics and metabolism of various benzodiazepines used as hypnotics. British Journal of Clinical Pharmacology 8: 7S–13S, 1979

    PubMed  Article  CAS  Google Scholar 

  • Cirignotta F, Mondini S, Zucconi M, Gerardi R, Farolfi A. Controlled polysomnographic study of the effects of benzodiaze-pine and non-benzodiazepine hypnotics (zolpidem) in obstructive sleep apnea patients: preliminary results. In Sauvanet et al. (Eds) Imidazopyridines in sleep disorders, pp. 297–304, Raven Press, New York, 1988

    Google Scholar 

  • Cohn JB, Wilcox CS, Bremner J, Ettinger M. Hypnotic efficacy of estazolam compared with flurazepam in outpatients with insomnia. Journal of Clinical Pharmacology 31: 747–750, 1991

    PubMed  CAS  Google Scholar 

  • Coleman RM, Roffwarg HP, Kennedy SJ, Guilleminault C, Cinque J, et al. Sleep-wake disorders based on a polysomnographic diagnosis: a national cooperative study. Journal of American Medical Association 247: 997–1003, 1982

    Article  CAS  Google Scholar 

  • Consensus Development Conference. Drugs and insomnia: the use of medication to promote sleep. Journal of the American Medical Association 251: 2410–2414, 1984

    Article  Google Scholar 

  • Diagnostic Classification Steering Committee. International classification of sleep disorders: diagnostic and coding manual. American Sleep Disorders Association, Rochester, Minnesota, 1990

    Google Scholar 

  • Divoll M, Greenblatt DJ, Harmatz JS, Shader RI. Effect of age and gender on disposition of temazepam. Journal of Pharmaceutical Sciences 70: 1104–1107, 1981

    PubMed  Article  CAS  Google Scholar 

  • Dubruc C, Thenot JP, Rosen P, Bianchetti G, Morselli PL. Pharmacokinetics of zolpidem as a function of gender. IV World Conference on Clinical Pharmacology and Therapeutics, Mannheim-Heidelberg, July 23–28, 1989

  • Ghoneim MM, Mewaldt SP. Benzodiazepines and human memory: a review. Anesthesiology 72: 926–938, 1990

    PubMed  Article  CAS  Google Scholar 

  • Gillin JC, Byerley WF. The diagnosis and management of insomnia. New England Journal of Medicine 322: 239–248, 1990

    PubMed  Article  CAS  Google Scholar 

  • Goa K, Heel R. Zopiclone: a review of pharmacodynamics and pharmacokinetic properties and therapeutic efficacy as an hypnotic. Drugs 32: 48–65, 1986

    PubMed  Article  CAS  Google Scholar 

  • Greenblatt DJ. Benzodiazepine hypnotics: sorting the pharmacological facts. Journal of Clinical Psychiatry 52 (Suppl.): 4–10, 1991

    PubMed  Google Scholar 

  • Greenblatt DJ. Pharmacology of benzodiazepine hypnotics. Journal of Clinical Psychiatry 53 (Suppl.): 7–13, 1992

    PubMed  Google Scholar 

  • Greenblatt DJ, Shader RI, Divoll M, Harmatz JS. Benzodiaze-pines: a summary of pharmacokinetic properties. British Journal of Clinical Pharmacology 11: 11S–16S, 1981

    PubMed  Article  CAS  Google Scholar 

  • Hauri P. Primary Insomnia. In Kryger et al. (Eds) Principles and practice of sleep medicine, pp. 442–447, W.B. Saunders, Philadelphia, 1989

    Google Scholar 

  • Huff JS, Plunkett HG. Anterograde amnesia following triazolam use in two emergency room physicians. Journal of Emergency Medicine 7: 153–155, 1989

    PubMed  Article  CAS  Google Scholar 

  • Hishikawa Y. Appropriate use of benzodiazepines in insomnia: clinical update. Journal of Clinical Psychiatry 52: 10–13, 1991

    PubMed  Google Scholar 

  • Jonas JM. Idiosyncratic side effects of short half-life benzodiazepine hypnotics: Fact or fancy? Human Psychopharmacology, in press, 1993

  • Julou L, Bardonne M, Blanchard J, Garret G, Stutzmann JM. Pharmacological studies on zopiclone. International Pharmacopsychiatry 17 (Suppl.): 46–58, 1982

    PubMed  CAS  Google Scholar 

  • Lacks P. Stimulus control in a group setting. In Hauri (Ed.) Case studies in insomnia, pp. 29–47, Plenum Medical, New York, 1991

    Google Scholar 

  • Langtry HD, Benfield P. Zolpidem: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 40: 291–313, 1990

    PubMed  Article  CAS  Google Scholar 

  • McInnes GT, Bunting EA, Ings RMJ, Robinson J, Ankier SI. Pharmacokinetics and pharmacodynamics following single and repeated nightly administration of loprazolam, a new benzodiazepine hypnotic. British Journal of Clinical Pharmacology 19: 649–656, 1985

    PubMed  Article  CAS  Google Scholar 

  • Mendelson WB. Safety of short-acting benzodiazepine hypnotics in patients with impaired respiration. Correspondence. American Journal of Psychiatry 148: 1401, 1991

    PubMed  CAS  Google Scholar 

  • Miller LG, Greenblatt DJ, Abernethy DR, Friedman H, Luu MD, et al. Kinetics, brain uptake, and receptor binding characteristics of flurazepam and its metabolites. Psychopharmacology 94: 386–391, 1988

    PubMed  Article  CAS  Google Scholar 

  • Momose T, Ishii S, Kuge T. Controlled comparison of estazolam and nitrazepam as hypnotics on the preoperative sleep night. Current Therapeutic Research 19: 277–291, 1976

    PubMed  CAS  Google Scholar 

  • Morris HH, Estes ML. Traveler’s amnesia: transient global amnesia secondary to triazolam. Journal of the American Medical Association 258: 945–946, 1987

    PubMed  Article  Google Scholar 

  • Muir JF, DeFouilloy P, Broussier R, Locquet R, Maillard F. Comparative study of the effects of zopiclone and placebo on respiratory function in patients with chronic obstructive respiratory insufficiency. International Clinical Psychopharmacology 5 (Suppl): 85–94, 1990

    PubMed  Google Scholar 

  • Murciano D, Aubier M, Palacios S, Pariente R. Comparison of Zolpidem (Z), Triazolam (T) and Flunitrazepam (F) effects on arterial blood gases and control of breathing in patients with severe chronic obstructive pulmonary disease (COPD). Chest 97 (Suppl.): 51S–52S, 1990

    PubMed  CAS  Google Scholar 

  • National Institutes of Health Consensus Development Conference Statement: The treatment of sleep disorders of older people. Sleep 14: (2): 169–177, 1990

    Google Scholar 

  • National Sleep Foundation. Sleep in America. Gallup Organization, Princeton, New Jersey, 1991

    Google Scholar 

  • Palminteri R, Narbonne G. Safety profile of zolpidem. In Sauvanet JP, et al. (Eds) Imidazopyridines in sleep disorders, pp. 351–361, Raven Press, New York, 1988

    Google Scholar 

  • Patterson J. Triazolam syndrom in the elderly. Southern Medical Journal 80: 1425–1426, 1987

    PubMed  Article  CAS  Google Scholar 

  • Pierce DM, Franklin RA, Harry TVA, Nicholson AN. Pharmacodynamic correlates of modified absorption: studies with lormetazepam. British Journal of Clinical Pharmacology 18: 31–35, 1984

    PubMed  Article  CAS  Google Scholar 

  • Rhodes SP, Parry P, Hanning CD. A comparison of the effects of zolpidem and placebo on respiration and oxygen saturation during sleep in the healthy elderly. British Journal of Clinical Pharmacology 30: 817–824, 1990

    PubMed  Article  CAS  Google Scholar 

  • Roehrs T, Zorick F, Lord N, Koshorek GL, Roth T. Dose-related effects of estazolam on sleep of patients with insomnia. Journal of Clinical Psychopharmacology 3: 152–156, 1983

    PubMed  CAS  Google Scholar 

  • Roth T, Roehrs T, Zorick F, Conway W. Pharmacological effects of sedative-hypnotics, narcotics, analgesics and alcohol during sleep. Medical Clinics of North America 69: 1281–1288, 1985

    PubMed  CAS  Google Scholar 

  • Roth T, Roehrs TA. Issues in the use of benzodiazepine therapy. Journal of Clinical Psychiatry 53: (Suppl.): 14–18, 1992

    PubMed  Google Scholar 

  • Shader RI, Greenblatt DJ. Triazolam and anterograde amnesia: all is not well in the Z-zone. Journal of Clinical Psychopharmacology 3: 272, 1983

    Google Scholar 

  • Schogt B, Conn D. Paranoid symptoms associated with triazolam. Canadian Journal of Psychiatry 30: 462–463, 1985

    CAS  Google Scholar 

  • Task Force Report of the American Psychiatric Association. Benzodiazepine dependence, toxicity and abuse. American Psychiatric Association, Washington, 1990

    Google Scholar 

  • Van der Kroef C. Reactions to triazolam. Lancet 2: 526, 1979

    PubMed  Article  Google Scholar 

  • Vuori E, Klaukka T. Triazolam and violent deaths. Lancet 339: 676, 1992

    PubMed  Article  CAS  Google Scholar 

  • Walsh JK, Targum SD, Pegram V, Allen RP, Fillingim JM, et al. A multi-center clinical investigation of estazolam: short-term efficacy. Current Therapeutic Research 36: 866–874, 1984

    Google Scholar 

  • Zampaglione N, Hilbert JM, Ning J, Menger C, Gural R, et al. Disposition and metabolic fate of 14C-quazepam in man. Drug Metabolism and Disposition 13: 25–29, 1985

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Sleep/Wake Disorders Center, Department of Psychiatry and Behavioral Science, State University of New York at Stony Brook, HSC-T-10 Room 040, Stony Brook, New York, New York, NY 11794-8101, USA

    Marta Maczaj

Authors
  1. Marta Maczaj
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Maczaj, M. Pharmacological Treatment of Insomnia. Drugs 45, 44–55 (1993). https://doi.org/10.2165/00003495-199345010-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199345010-00005

Keywords

  • Zolpidem
  • Triazolam
  • Zopiclone
  • Flurazepam
  • Obstructive Sleep Apnoea Syndrome